Contact
Please use this form to send email to PR contact of this press release:
Genentech Announces Positive Phase I Results of Its Oral GLP-1 Receptor Agonist CT-996 for the Treatment of People With Obesity
TO:
Please use this form to send email to PR contact of this press release:
Genentech Announces Positive Phase I Results of Its Oral GLP-1 Receptor Agonist CT-996 for the Treatment of People With Obesity
TO: